You are here: Home: BCU 4|2002: Program Supplement: Sentinel lymph node biopsy

Sentinel Lymph Node Biopsy (SLNB)

Miami meeting attendees:

What technique do you utilize in performing sentinel lymph node biopsies?

Is SLNB a good option for a woman with a 2 cm lesion high in the upper-outer quadrant in the tail of Spence?

Have you done SLNB in a woman with DCIS?


Sentinel lymph node biopsy (SLNB) has been shown to be accurate using a variety of techniques and a variety of dyes and tracers. Most surgeons performing sentinel node biopsies utilize both dye and radioisotopes to identify the sentinel node. Overall, surgeons report that about two-thirds of the SLNBs performed are negative, sparing the patient the need for axillary dissection.

SLNB is now being utilized in some patients with DCIS and more than one-third of surgeons have done an SLNB in a DCIS patient.

Cox CE. Lymphatic mapping in breast cancer: Combination technique. Ann Surg Oncol 2001; 8 ( 9 Suppl):67S-70S. Abstract

Derossis AM et al. A trend analysis of the relative value of blue dye and isotope localization in 2,000 consecutive cases of sentinel node biopsy for breast cancer. J Am Coll Surg 2001; 193 ( 5 ) : 4 7 3 - 8 . Abstract

Hansen NM. Blue versus hot: Learning the techniques with dye and isotopes. Ann Surg Oncol 2001;8(9 Suppl):64S-66S. Abstract

Lucci A Jr et al. National practice patterns of sentinel lymph node dissection for breast carcinoma. J Am Coll Surg 2001;192(4):453-8. Abstract

When Is Sentinel Lymph Node Biopsy (SLNB) Appropriate?

Miami meeting attendees:

Is SLNB currently the standard of care for patients with clinical T1NO disease?

Is SLNB useful after neoadjuvant chemotherapy?

Is SLNB a good option for a woman with 2 lesions in different quadrants
(upper-outer and lower-inner) of the breast?


More than two-thirds of the surgeons believe that SLNB is now the standard of care, although both the American College of Surgeons and the NSABP have current clinical trials addressing this question. However, there is considerable controversy about the role of SLNB in several groups of patients, including patients who have undergone neoadjuvant therapy and those with more than one lesion in the same breast .

Haid A et al. Is sentinel lymph node biopsy reliable and indicated after preoperative chemotherapy in patients with breast carcinoma? Cancer 2001;92:1080-4. Abstract

Julian TB et al. Sentinel lymph node biopsy after neoadjuvant chemotherapy for breast cancer. Am J Surg 2001;182(4):407-10. Abstract

Klauber-DeMore N et al. Sentinel lymph node biopsy: Is it indicated in patients with high-risk ductal carcinoma-in-situ and ductal carcinoma-in-situ with microinvasion? Ann Surg Oncol 2000;7(9):636-42. Abstract

Pendas S et al. Sentinel node biopsy in ductal carcinoma in situ patients. Ann Surg Oncol 2000 ; 7 : 15-20. Abstract

Stearns V et al. Sentinel lymphadenectomy after neoadjuvant chemotherapy for breast cancer may reliably represent the axilla except for inflammatory breast cancer. Ann Surg Oncol 2002;9(3):235-42. Abstract

Table of Contents Top of Page

 

 

Home · Search

Main menu

PROGRAM SUPPLEMENT
Editor's Note
Local and systemic therapy of DCIS
Adjuvant systemic therapy
Neoadjuvant systemic therapy
Treatment of metastatic disease
Management of patients with HER2-positive disease
Sentinel lymph node biopsy
Postmastectomy radiation therapy
Breast reconstruction
Local recurrence
Other topics
Tumor board cases
 
Home · Contact us
Terms of use and general disclaimer